The global remote patient monitoring market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2033, exhibiting a growth rate (CAGR) of 12.9% during 2025-2033. The market is expanding rapidly, driven by rising geriatric population across the globe, increasing prevalence of chronic disease, rapid technological advancements, imposition of supportive government policies, and a growing demand for personalized and preventive healthcare.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 1.7 Billion |
Market Forecast in 2033 | USD 5.0 Billion |
Market Growth Rate (2025-2033) | 12.9% |
Rising Geriatric Population Across the Globe
The demographic shift towards geriatric population has profound implications for healthcare systems. As people age, the incidence of chronic diseases such as diabetes, cardiovascular disease, and respiratory conditions increases, necessitating continuous monitoring to manage these health issues effectively. Based on a report by the Survey on Health, Ageing and Retirement in Europe (SHARE), about 37% of people aged 65 and over reported having at least two chronic diseases on average across EU countries. Women report multiple chronic diseases more often than men (41% versus 32% on average). Among people aged 80 and over, 56% of women and 47% of men report multiple chronic diseases on average across EU countries. Remote patient monitoring (RPM) systems provide a crucial solution by enabling healthcare providers to track patient health data in real-time, thereby facilitating timely interventions before acute episodes occur. Additionally, RPM empowers elderly patients to maintain independence and stay in the comfort of their homes while being able to receive high-quality healthcare.
Increasing Healthcare Costs and the Need for Efficient Solutions
Healthcare costs are escalating worldwide due to the increasing burden of chronic diseases, rising healthcare service prices, and the growing demand for advanced medical treatments. Chronic conditions account for 90% of the healthcare costs in the U.S. annually. Heart diseases and strokes cost the healthcare system $216 billion per year and cause $147 billion in lost productivity on the job. This cost can be reduced with timely assistance provided to patients using a remote monitoring system. It can delay emergency room visits and hospitalizations as telemedicine applications help in digitizing and automating critical tasks, which, in turn, reduces hospital administrative tasks. Also, each year, 3.6 million people in the United States do not obtain medical care due to transportation issues. This drives the need to make healthcare infrastructure more accessible, thereby increasing the remote patient monitoring market growth.
Rapid Technological Advancements in Healthcare Devices and Connectivity
The rapid advancement in medical technology is significantly promoting the remote patient monitoring demand. Innovations in wearable health devices and medical sensors are making it easier and more efficient to monitor many health parameters, which include heart rate, blood pressure, glucose levels, and oxygen saturation, outside of traditional clinical settings. The wearable medical devices market is surging at a rapid pace of 19.2% annually. It is also expected to touch US$ 143.2 billion by 2032. Moreover, companies are innovating new products to improve patient satisfaction. For instance, in July 2022, Biobeat partnered with Medidata Solutions and became part of the Sensor Cloud Network. By using Biobeat’s medical-grade wearables, they are able to enhance clinical trials with vital signs collection to generate real-world evidence remotely and conveniently from the patient’s home. These devices are equipped with user-friendly features, like real-time data transmission, alerts, and long battery life, making them accessible to a broad range of patients.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on device type, application, and end-use.
Breakup by Device Type:
Heart rate monitor accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the device type. This includes blood pressure monitor, glucose monitor, heart rate monitor, pulse oximeters, respiratory monitor, and others. According to the report, heart rate monitor represented the largest segment.
According to the remote patient monitoring market analysis and trends, heart rate monitor represented the largest segment. A remote heart rate monitor is a device that continuously tracks the number of heartbeats per minute. It usually consists of a chest strap sensor or a wrist-based sensor that detects each heartbeat. Some advanced models may also include features like tracking irregular heartbeats or measuring other cardiac parameters. Heart rate monitors enable individuals to proactively manage their cardiovascular health, leading to improved outcomes and a better quality of life.
Breakup by Application:
Cardiovascular diseases treatment and monitoring holds the largest share of the industry
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes cancer treatment, cardiovascular diseases treatment and monitoring, diabetes treatment, sleep disorder treatment, weight management and fitness monitoring, and others. According to the report, cardiovascular diseases treatment and monitoring accounted for the largest market share.
According to the remote patient monitoring report and outlook, cardiovascular diseases treatment and monitoring accounted for the largest market share. RPM plays a significant role in the treatment and management of cardiovascular diseases. By using devices like heart rate monitors, blood pressure monitors, and electrocardiogram (ECG) machines that can be used at home, patients and healthcare providers can track vital cardiac parameters in real-time. This constant monitoring is crucial for individuals suffering from conditions like hypertension, heart failure, or arrhythmias. It allows healthcare providers to make immediate adjustments to treatment plans, thereby potentially preventing hospital readmissions and improving patient outcomes, thereby positively impacting the remote patient monitoring market revenue.
Breakup by End-Use:
Hospitals and clinics represent the leading market segment
The report has provided a detailed breakup and analysis of the market based on the end-use. This includes hospitals and clinics, homecare settings, and others. According to the report, hospitals and clinics represented the largest segment.
Based on the remote patient monitoring market statistics and overview, hospitals and clinics hold the largest share as RPM serves as an extension of traditional healthcare services, which enhances the efficiency and effectiveness of medical care. By employing RPM devices, healthcare professionals monitor the vital signs of patients, chronic conditions, and post-operative recovery metrics even when the patients are not in the immediate care facility. This technology aids in resource allocation, which allows clinicians to prioritize patients based on the severity of their conditions, thereby streamlining hospital operations.
Breakup by Region:
North America leads the market, accounting for the largest remote patient monitoring market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for remote patient monitoring.
As per the remote patient monitoring market trends and forecast, North America is leading the market. The increasing geriatric population in the region is driving the demand for RPM solutions to manage health conditions without frequent hospital visits. In addition to this, the rising awareness about the benefits of RPM solutions and services among the masses is contributing to the market growth. Besides this, the growing utilization of mobile health (m-health) applications is positively influencing the remote patient monitoring market recent opportunities and developments.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment
|
Device Types Covered | Blood Pressure Monitor, Glucose Monitor, Heart Rate Monitor, Pulse Oximeters, Respiratory Monitor, Others |
Applications Covered | Cancer Treatment, Cardiovascular Diseases Treatment and Monitoring, Diabetes Treatment, Sleep Disorder Treatment, Weight Management and Fitness Monitoring, Others |
End-Uses Covered | Hospitals and Clinics, Homecare Settings, Others |
Regions Covered | North America, Asia Pacific, Europe, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Abbott Laboratories, AMD Global Telemedicine, Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Dexcom, Inc., GE Healthcare, Inc. (Danaher Corporation), Honeywell International, Inc., Koninklijke Philips N.V., Medtronic, Inc., Nihon Kohden Corporation, OSI Systems, Inc., Roche Holding AG, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global remote patient monitoring market was valued at USD 1.7 Billion in 2024.
We expect the global remote patient monitoring market to exhibit a CAGR of 12.9% during 2025-2033.
The rising prevalence of various cardiovascular diseases, among the geriatric population who are more susceptible to chronic conditions, represents one of the key factors driving the global remote patient monitoring market.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of remote patient monitoring services, enabling health professionals to remotely monitor patients infected with the coronavirus infection and improve the quality of medical care.
Based on the device type, the global remote patient monitoring market can be categorized into blood pressure monitor, glucose monitor, heart rate monitor, pulse oximeters, respiratory monitor, and others. Among these, heart rate monitor device holds the majority of the total market share.
Based on the application, the global remote patient monitoring market has been segmented into cancer treatment, cardiovascular diseases treatment and monitoring, diabetes treatment, sleep disorder treatment, weight management and fitness monitoring, and others. Currently, cardiovascular diseases treatment and monitoring represent the largest market share.
Based on the end-use, the global remote patient monitoring market can be bifurcated into hospitals and clinics, homecare settings, and others. Among these, hospitals and clinics currently account for the majority of the global market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global remote patient monitoring market include Abbott Laboratories, AMD Global Telemedicine Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Dexcom, Inc., GE Healthcare Inc. (Danaher Corporation), Honeywell International Inc., Koninklijke Philips N.V., Medtronic Inc., Nihon Kohden Corporation, OSI Systems Inc., Roche Holding AG, etc.